Mirati Therapeutics, Inc. Human Resources Contracts & Agreements
30 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Compensation Agreements (10)
- Consulting Agreements (3)
- Employment Agreements (7)
- Separation Agreements (5)
- Severance Agreements (1)
- Position and Compensation Adjustment Letter, dated August 23, 2023, by and between (Filed With SEC on November 6, 2023)
- Severance Policy for Senior Vice Presidents and Vice Presidents, dated October 11, 2022, by and between Mirati Therapeutics, Inc. and Aaron A. Ondrey (Filed With SEC on November 6, 2023)
- Employment Agreement, dated June 29, 2022, by and between (Filed With SEC on November 6, 2023)
- Consulting Agreement Amendment No 2., dated September 22, 2023, by and between (Filed With SEC on November 6, 2023)
- Consulting Agreement Amendment No 1., dated September 12, 2023, by and between (Filed With SEC on November 6, 2023)
- Consulting Agreement, dated September 9, 2023, by and between (Filed With SEC on November 6, 2023)
- Separation Agreement and Release, dated August 7, 2023, by and between (Filed With SEC on November 6, 2023)
- Employment Agreement, dated April 12, 2023, by and between the Registrant and John B. Moriarty, Jr (Filed With SEC on August 8, 2023)
- Non-Employee Director Compensation Policy, Amended and Restated June 22, 2023 (Filed With SEC on August 8, 2023)
- Employment Agreement, dated August 17, 2022, by and between the Registrant and Alan Sandler, M.D (Filed With SEC on February 28, 2023)
- Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2023)
- Employment Agreement, dated April 7, 2022, by and between the Registrant and Laurie D. Stelzer (Filed With SEC on August 3, 2022)
- Separation Agreement and Release, dated December 15, 2021, by and between the Registrant and Dan Faga (Filed With SEC on February 28, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2022)
- Employment Agreement, dated September 17, 2021, by and between the Registrant and David (Filed With SEC on November 8, 2021)
- Third Amendment to Amended and Restated Employment Agreement, dated September 20, 2021, by and between the Registrant and Dr. Charles M. Baum (Filed With SEC on November 8, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)
- Separation and Release Agreement, dated June 1, 2020, by and between the Registrant and Isan Chen (Filed With SEC on August 6, 2020)
- Separation and Release Agreement, dated January 3, 2020, by and between the Registrant and Chris LeMasters (Filed With SEC on May 7, 2020)
- Separation and Release Agreement, dated January 3, 2020, by and between the Registrant and Jamie Donadio (Filed With SEC on May 7, 2020)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Amended and Restated 2013 Equity Incentive Plan (Filed With SEC on February 26, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 26, 2020)
- Amended and Restated 2013 Equity Incentive Plan, as amended, and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder (Filed With SEC on August 5, 2019)
- Amended and Restated 2013 Equity Incentive Plan and Form of Stock Option Grant Notice and Form of Stock Option Agreement thereunder (Filed With SEC on February 28, 2019)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2019)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 7, 2018)
- MIRATI THERAPEUTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED: SEPTEMBER 9, 2014 EFFECTIVE DATE: SEPTEMBER 9, 2014 AMENDED AND RESTATED:... (Filed With SEC on May 4, 2017)
- AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2017)
- MIRATI THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MAY 8, 2013 APPROVED BY THE STOCKHOLDERS: JUNE 21, 2013 AMENDED AND APPROVED BY THE BOARD:... (Filed With SEC on November 3, 2016)
- Mirati Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy Adopted: September 9, 2014 Effective Date: September 9, 2014 Amended and Restated:... (Filed With SEC on March 9, 2016)
